Arrowhead Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.

About ARWR

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.

CEO

Christopher Richard Anzalone

CEOChristopher Richard Anzalone

Employees

609

Employees609

Headquarters

Pasadena, California

HeadquartersPasadena, California

Founded

1989

Founded1989

Employees

609

Employees609

ARWR Key Statistics

Market cap

2.12B

Market cap2.12B

Price-Earnings ratio

-11.13

Price-Earnings ratio-11.13

Dividend yield

—

Dividend yield—

Average volume

1.93M

Average volume1.93M

High today

$15.39

High today$15.39

Low today

$14.68

Low today$14.68

Open price

$14.91

Open price$14.91

Volume

2.14M

Volume2.14M

52 Week high

$30.41

52 Week high$30.41

52 Week low

$9.57

52 Week low$9.57

ARWR News

TipRanks 8h

Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges

Arrowhead Pharmaceuticals, Inc. ((ARWR)) has held its Q2 earnings call. Read on for the main highlights of the call. Protect Your Portfolio Against Market Unce...

Simply Wall St 2d

Arrowhead Pharmaceuticals, Inc.'s Shares Bounce 30% But Its Business Still Trails The Industry

Arrowhead Pharmaceuticals, Inc. ( ) shareholders are no doubt pleased to see that the share price has bounced 30% in the last month, although it is still strugg...

Analyst ratings

69%

of 16 ratings

Buy

68.8%

Hold

31.3%

Sell

People also own

Based on the portfolios of people who own ARWR. This list is generated using Robinhood data, and it’s not a recommendation.